JPMorgan Chase & Co. disposed of 33.75 million shares of GENSCRIPT BIO (01548) off-exchange at an average of HKD 32.7394 per share on September 15, 2026, involving about HKD 1.10 billion. The transaction was an off-exchange cash consideration, not a direct secondary-market dealing.
Prior to the disposal, JPMorgan Chase & Co.'s long position in GENSCRIPT BIO was 162.39 million shares, representing 7.37%; following the disposal, the holding changed to 128.64 million shares, with the long position ratio falling to 5.64%.
Source: Hong Kong Exchanges and Clearing Limited.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments